Home
Iovance Biotherapeutics IOVA spent $170K on lobbying in Q1 2023 · Medicare
Trade details
- Type
- Lobbying report
- Amount
- $170,000
- Quarter
- Q1 2023
- Client
- Iovance Biotherapeutics
- Reported
- 23/03/14
Down 34.6% from last quarter
What else happened in Iovance Biotherapeutics around then
Filed or reported within 30 days of the trade day · 23/03/01~23/04/30Iovance Biotherapeutics's other lobbying reports
- Iovance Biotherapeutics
LobbyingIovance Biotherapeutics
LobbyingIovance Biotherapeutics
IOVA
Under $5,000
Under $5,000
Reported 23/07/20
for Q2 2023
- Iovance Biotherapeutics
LobbyingIovance Biotherapeutics
LobbyingIovance Biotherapeutics
IOVA
Under $5,000
Under $5,000
Reported 23/07/20
for Q2 2023
- Iovance Biotherapeutics
LobbyingIovance Biotherapeutics
LobbyingIovance Biotherapeutics
IOVA
Under $5,000
Under $5,000
Reported 23/04/20
for Q1 2023
- Iovance Biotherapeutics
LobbyingIovance Biotherapeutics
LobbyingIovance Biotherapeutics
IOVA
Under $5,000
Under $5,000
Reported 23/04/20
for Q1 2023
- Iovance Biotherapeutics
LobbyingIovance Biotherapeutics
LobbyingIovance Biotherapeutics
IOVA
$260K
$260K
Reported 23/01/20
for Q4 2022